67 related articles for article (PubMed ID: 18524848)
21. C-H-Functionalization logic guides the synthesis of a carbacyclopamine analog.
Rabe S; Moschner J; Bantzi M; Heretsch P; Giannis A
Beilstein J Org Chem; 2014; 10():1564-9. PubMed ID: 25161712
[TBL] [Abstract][Full Text] [Related]
22. Cyclopamine analogs bearing exocyclic methylenes are highly potent and acid-stable inhibitors of hedgehog signaling.
Moschner J; Chentsova A; Eilert N; Rovardi I; Heretsch P; Giannis A
Beilstein J Org Chem; 2013; 9():2328-35. PubMed ID: 24367396
[TBL] [Abstract][Full Text] [Related]
23. Colon Cancer Stem Cells: Bench-to-Bedside-New Therapeutical Approaches in Clinical Oncology for Disease Breakdown.
Di Franco S; Mancuso P; Benfante A; Spina M; Iovino F; Dieli F; Stassi G; Todaro M
Cancers (Basel); 2011 Apr; 3(2):1957-74. PubMed ID: 24212791
[TBL] [Abstract][Full Text] [Related]
24. Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approach.
Chaturvedi NK; Rajule RN; Shukla A; Radhakrishnan P; Todd GL; Natarajan A; Vose JM; Joshi SS
Mol Cancer Ther; 2013 Oct; 12(10):2006-17. PubMed ID: 23963361
[TBL] [Abstract][Full Text] [Related]
25. Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma.
Macha MA; Batra SK; Ganti AK
Cancer Manag Res; 2013; 5():197-203. PubMed ID: 23940421
[TBL] [Abstract][Full Text] [Related]
26. BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
Siddique HR; Parray A; Tarapore RS; Wang L; Mukhtar H; Karnes RJ; Deng Y; Konety BR; Saleem M
PLoS One; 2013; 8(5):e60664. PubMed ID: 23671559
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers of parathyroid carcinoma.
Erovic BM; Harris L; Jamali M; Goldstein DP; Irish JC; Asa SL; Mete O
Endocr Pathol; 2012 Dec; 23(4):221-31. PubMed ID: 23001705
[TBL] [Abstract][Full Text] [Related]
28. The utility of hedgehog signaling pathway inhibition for cancer.
Sahebjam S; Siu LL; Razak AA
Oncologist; 2012; 17(8):1090-9. PubMed ID: 22851551
[TBL] [Abstract][Full Text] [Related]
29. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
Blotta S; Jakubikova J; Calimeri T; Roccaro AM; Amodio N; Azab AK; Foresta U; Mitsiades CS; Rossi M; Todoerti K; Molica S; Morabito F; Neri A; Tagliaferri P; Tassone P; Anderson KC; Munshi NC
Blood; 2012 Dec; 120(25):5002-13. PubMed ID: 22821765
[TBL] [Abstract][Full Text] [Related]
30. Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma.
Ramirez E; Singh RR; Kunkalla K; Liu Y; Qu C; Cain C; Multani AS; Lennon PA; Jackacky J; Ho M; Dawud S; Gu J; Yang S; Hu PC; Vega F
Leuk Res; 2012 Oct; 36(10):1267-73. PubMed ID: 22809693
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog pathway as a drug target: Smoothened inhibitors in development.
Lin TL; Matsui W
Onco Targets Ther; 2012; 5():47-58. PubMed ID: 22500124
[TBL] [Abstract][Full Text] [Related]
32. Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms.
Ok CY; Singh RR; Vega F
Am J Pathol; 2012 Jan; 180(1):2-11. PubMed ID: 22056910
[TBL] [Abstract][Full Text] [Related]
33. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.
Pérez-Galán P; Dreyling M; Wiestner A
Blood; 2011 Jan; 117(1):26-38. PubMed ID: 20940415
[TBL] [Abstract][Full Text] [Related]
34. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
Mimeault M; Batra SK
Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
[TBL] [Abstract][Full Text] [Related]
35. Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer.
Barakat MT; Humke EW; Scott MP
Trends Mol Med; 2010 Aug; 16(8):337-48. PubMed ID: 20696410
[TBL] [Abstract][Full Text] [Related]
36. Targeting Hedgehog--a cancer stem cell pathway.
Merchant AA; Matsui W
Clin Cancer Res; 2010 Jun; 16(12):3130-40. PubMed ID: 20530699
[TBL] [Abstract][Full Text] [Related]
37. Smoothened as a new therapeutic target for human osteosarcoma.
Hirotsu M; Setoguchi T; Sasaki H; Matsunoshita Y; Gao H; Nagao H; Kunigou O; Komiya S
Mol Cancer; 2010 Jan; 9():5. PubMed ID: 20067614
[TBL] [Abstract][Full Text] [Related]
38. Distinct expression patterns of hedgehog ligands between cultured and primary colorectal cancers are associated with aberrant methylation of their promoters.
Fu X; Deng H; Zhao L; Li J; Zhou Y; Zhang Y
Mol Cell Biochem; 2010 Apr; 337(1-2):185-92. PubMed ID: 19856079
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines.
Mizuarai S; Kawagishi A; Kotani H
Mol Cancer; 2009 Jul; 8():44. PubMed ID: 19575820
[TBL] [Abstract][Full Text] [Related]
40. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis.
Hofmann I; Stover EH; Cullen DE; Mao J; Morgan KJ; Lee BH; Kharas MG; Miller PG; Cornejo MG; Okabe R; Armstrong SA; Ghilardi N; Gould S; de Sauvage FJ; McMahon AP; Gilliland DG
Cell Stem Cell; 2009 Jun; 4(6):559-67. PubMed ID: 19497284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
